Several peer-reviewed publications describe research on Ipamorelin and related ghrelin-mimetic peptides: Venkova K, Mann W, Nelson R, Greenwood-Van Meerveld B
We are currently amid an evolving revolution in obesity pharmacotherapy, with increasingly efficacious anti-obesity medicines (AOMs), incorporating uni-, bi- and trimolecular incretin receptor agonists [8, 9]
What they found: In the control group 70 % of rats died within 30 days In the BPC-157 group only 10 % died Histology: faster formation of collaterals, normalization of portal vein pressure, 80 % reduction in liver thromboses Why it matters: These are extreme conditions
After once-weekly injections for 68 weeks, patients on the higher 12-mg dose of retatrutide who lost an average of 28.7% of body weight (average weight loss of 71.2 pounds from a baseline of 248.5 pounds) were those who remained in the study and did not drop out
These fats slow down digestion and trigger satiety signals that help control portions and reduce cravings